Literature DB >> 7968265

Characterization of lipid hydroperoxides generated by photodynamic treatment of leukemia cells.

G J Bachowski1, W Korytowski, A W Girotti.   

Abstract

A new technique, high-performance liquid chromatography with reductive mode electrochemical detection on a mercury drop (HPLC-EC), has been used for analyzing lipid hydroperoxide (LOOH) formation in photooxidatively stressed L1210 leukemia cells. Highly specific and sensitive for peroxides (detection limits < 0.5 pmol for cholesterol hydroperoxides and < 50 pmol for phospholipid hydroperoxides), this approach allows different classes of LOOH to be separated and determined in minimally damaged cells. L1210 cells in serum-containing growth medium were irradiated in the presence of merocyanine 540 (MC540), a lipophilic photosensitizing dye. Lipid extracts from cells exposed to a light fluence of 0.11 J/cm2 (which reduced clonally assessed survival by 30%) showed 12-15 well-defined peaks in HPLC-EC. None of these peaks was observed when cells were irradiated without MC540 or when dye/light-treated samples were reduced with triphenylphosphine prior to analysis. Three peaks of relatively low retention time (< 12 min) were assigned to the following species by virtue of comigration with authentic standards: 3 beta-hydroxy-5 alpha-cholest-6-ene-5-hydroperoxide (5 alpha-OOH), 3 beta-hydroxycholest-4-ene-6 beta-hydroperoxide (6 beta-OOH), and 3 beta-hydroxycholest-5-ene-7 alpha/7 beta-hydroperoxide (7 alpha/7 beta-OOH). Formation of 5 alpha-OOH and 6 beta-OOH (single oxygen adducts) was confirmed by subjecting [14C]cholesterol-labeled cells to relatively high levels of photooxidation and analyzing extracted lipids by HPLC with radiochemical detection. Material represented in a major peak at 18-22 min on HPLC-EC was isolated in relatively large amounts by semipreparative HPLC and shown to contain phospholipid hydroperoxides (predominantly phosphatidylcholine species, PCOOH) according to the following criteria: (i) decay of 18-22 min peak during Ca2+/phospholipase A2 treatment, with reciprocal appearance of fatty acid hydroperoxides; (ii) reduction of peroxide during treatment with reduced glutathione and phospholipid hydroperoxide glutathione peroxidase, but not glutathione peroxidase; and (iii) comigration with PCOOH standards in thin-layer chromatography. HPLC-EC analysis revealed quantifiable amounts of PCOOH and ChOOH at a light fluence that clonally inactivated < 10% of the cells, which allows for the possibility that photoperoxidative damage plays a causal role in cell killing.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7968265     DOI: 10.1007/BF02578241

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  34 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

Review 2.  Merocyanine 540.

Authors:  F Sieber
Journal:  Photochem Photobiol       Date:  1987-12       Impact factor: 3.421

Review 3.  The electroanalytical approach to lipid peroxide determinations.

Authors:  M O Funk
Journal:  Free Radic Biol Med       Date:  1987       Impact factor: 7.376

4.  Photodynamic action of merocyanine 540 on artificial and natural cell membranes: involvement of singlet molecular oxygen.

Authors:  B Kalyanaraman; J B Feix; F Sieber; J P Thomas; A W Girotti
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Lipid photooxidation in erythrocyte ghosts: sensitization of the membranes toward ascorbate- and superoxide-induced peroxidation and lysis.

Authors:  A W Girotti; J P Thomas; J E Jordan
Journal:  Arch Biochem Biophys       Date:  1985-01       Impact factor: 4.013

6.  Non-reactivity of the selenoenzyme glutathione peroxidase with enzymatically hydroperoxidized phospholipids.

Authors:  A Grossmann; A Wendel
Journal:  Eur J Biochem       Date:  1983-10-03

7.  Ascorbate-enhanced lipid peroxidation in photooxidized cell membranes: cholesterol product analysis as a probe of reaction mechanism.

Authors:  G J Bachowski; J P Thomas; A W Girotti
Journal:  Lipids       Date:  1988-06       Impact factor: 1.880

8.  Photodynamic action of merocyanine 540 on leukemia cells: iron-stimulated lipid peroxidation and cell killing.

Authors:  F Lin; A W Girotti
Journal:  Arch Biochem Biophys       Date:  1993-02-01       Impact factor: 4.013

9.  Electrochemical detection of phospholipid hydroperoxides in reverse-phase high performance liquid chromatography.

Authors:  K Yamada; J Terao; S Matsushita
Journal:  Lipids       Date:  1987-02       Impact factor: 1.880

10.  Photoperoxidation of cholesterol in homogeneous solution, isolated membranes, and cells: comparison of the 5 alpha- and 6 beta-hydroperoxides as indicators of singlet oxygen intermediacy.

Authors:  W Korytowski; G J Bachowski; A W Girotti
Journal:  Photochem Photobiol       Date:  1992-07       Impact factor: 3.421

View more
  4 in total

Review 1.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

2.  Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2004-12       Impact factor: 3.631

3.  Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity.

Authors:  D Nowis; M Legat; T Grzela; J Niderla; E Wilczek; G M Wilczynski; E Głodkowska; P Mrówka; T Issat; J Dulak; A Józkowicz; H Waś; M Adamek; A Wrzosek; S Nazarewski; M Makowski; T Stokłosa; M Jakóbisiak; J Gołab
Journal:  Oncogene       Date:  2006-02-06       Impact factor: 9.867

Review 4.  Photoimmunotherapy of Ovarian Cancer: A Unique Niche in the Management of Advanced Disease.

Authors:  Shubhankar Nath; Mohammad Ahsan Saad; Michael Pigula; Joseph W R Swain; Tayyaba Hasan
Journal:  Cancers (Basel)       Date:  2019-11-27       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.